Integrated DNA Technologies (IDT) announced its acquisition of the oligonucleotide manufacturing business of GeneWorks in Australia.
GeneWorks will continue offering molecular and cell biology products and associated services.
IDT offers GeneWorks customers a broad range of manufacturing options for oligos as well as other high-quality products for genomics research.
IDT’s global leadership in nucleic acid synthesis provides GeneWorks customers with unrivaled manufacturing capabilities, design expertise, and fast turnaround times.
The acquisition expands IDT’s capacity for direct sales of genomic products in the Asia-Pacific region, following its recent establishment of sales offices in Japan and Korea.
Crosstree Capital Partners initiated this transaction on behalf of IDT.